- Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases
- Cause, Development, and Progression of Stiff-Person Syndrome
- Efficacy and Mechanism of Action of SCIg in Patients With Stiff Person Syndrome (SPS)
- HLA Analysis in Autoimmune Encephalitis and Related Disorders
- Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
- Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome
- Rituximab to Treat Stiff Person Syndrome
- Stem Cell Transplantation for Stiff Person Syndrome (SPS)
Clinical Trials
- A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
- A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With sJIA
- A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
- A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)
- A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
- A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)
- A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)
- An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis
- An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
- An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
- Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis
- Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
- Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
- Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
- Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)
- Phase II, Open Label, International, Multicentre Clinical Trial to Investigate Safety and Efficacy of Oral ITF2357 in Patients With Active Systemic Onset Juvenile Idiopathic Arthritis (SOJIA)
- Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
- Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection
- Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
- ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
- Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA
- Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)
- Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)
- Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
- Ultrasonography in Juvenile Idiopathic Arthritis
- Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
- Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
- Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma
- Assessing the Impact of Smoke-free Legislation on Perinatal Health in the Netherlands
- Changes in Sleep Patterns and Stress in Infants Entering Child Care
- Do Pacifiers Protect From Sudden Infant Death Syndrome (SIDS) Through an Increase in Upper Airway Patency?
- Effect of Crystalloids With Different SID on pH, and Urinary Electrolytes During General Anesthesia
- Enhancing Safe Sleep Practices of Urban Low-Income Mothers
- Evaluation of Safe Sleep for Babies: a Bassinet Distribution and Education Program
- Factors Influencing the Racial Disparity in Sudden Infant Death Syndrome (SIDS)
- Generations in Families Talking Safe Sleep
- Impact of Smoke-free Legislation on Early-life Mortality and Low Birth Weight in England
- Improving Infant Sleep Safety With the Electronic Health Record
- Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record
- Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS)
- Infant Care Practices Study
- Influence of Pacifiers on Breastfeeding Duration
- Magnetic Resonance Imaging Autopsy Study
- Parental Knowledge and Beliefs About Infant Sleep Position
- Sensory Integration (Processing) Disorder Among Children With Behavioral Insomnia and Children With Feeding Disorder
- Social Media and Risk Reduction Teaching-Enhanced Reach
- Study of the Impact of Parental Note Taking on the Effectiveness of Anticipatory Guidance
- The Inclined Position in Case of Respiratory Discomfort in the One Year Less Infant : Study on the Profits and the Risks in the Home
- The Paediatric Virtual Autopsy Trial
- Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study
- Comparison of the Results of Transcutaneous Carbon Dioxide and Oxygen Pressure in Premature Neonates Who Underwent MIST Under HHHFNC or Nasal CPAP Methods
- Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants
- Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment
- Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment – Validation Study
- Feasibility Study – Neofact
- LISA vs INSURE in Extremely Low Birth Weight Infants. A Manikin Study
- Premedication for Less Invasive Surfactant Administration
- Study on the Effects of Different Premedication for LISA on Stress and Cerebral Tissue Oxygenation in Preterm Infants
- Surfactant Administration by Insure or Thin Catheter
- Surfactant Nebulization for the Early Aeration of the Preterm Lung
- 9-ING-41Combined With Chemotherapy in Adolescents and Adults
- A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma
- A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
- A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
- A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma
- A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma
- A Study of PRT2527 in Patients With Advanced Solid Tumors
- A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors
- A Two-part Study to Characterize Drug-Drug Interaction Effects on Steady-State Pharmacokinetics of Oral Tazemetostat
- Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
- Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery
- Bevacizumab and Radiation Therapy for Sarcomas
- CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Solid Tumors
- CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
- Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
- Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
- Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy
- Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
- Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
- Detection of Circulating Tumor Cells in Patients With Sarcomas
- DHEA in Synovial Sarcoma Patients
- Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
- Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy
- Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma
- Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma
- Hypofractionated Radiotherapy With Sequential Chemotherapy in Primary Unresectable or Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall
- Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood
- MAGE-A4ᶜ¹º³²T for Multi-Tumor
- Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma
- Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
- NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
- NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)
- Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
- Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors
- Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
- Preoperative Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
- Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
- Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
- Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
- Sorafenib and Dacarbazine in Soft Tissue Sarcoma
- Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
- Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
- SPEARHEAD-3 Pediatric Study
- Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
- Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients With Synovial Sarcoma
- Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin
- Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
- Synovate Study for Synovial Sarcoma, Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma
- T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
- Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study
- Trial of CMB305 and Atezolizumab in Patients With Sarcoma
- Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
- Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases